135 related articles for article (PubMed ID: 7661568)
1. [Chemotherapy of uterine endometrial cancer].
Hayakawa S; Sato S; Takano T; Wagazuma S; Yajima A
Gan To Kagaku Ryoho; 1995 Aug; 22(9):1169-75. PubMed ID: 7661568
[TBL] [Abstract][Full Text] [Related]
2. [Therapy of advanced endometrial cancer].
Okada H; Yamamoto T
Gan To Kagaku Ryoho; 1990 Sep; 17(9):1848-55. PubMed ID: 2144105
[TBL] [Abstract][Full Text] [Related]
3. Lymph-vascular space invasion and number of positive para-aortic node groups predict survival in node-positive patients with endometrial cancer.
Watari H; Todo Y; Takeda M; Ebina Y; Yamamoto R; Sakuragi N
Gynecol Oncol; 2005 Mar; 96(3):651-7. PubMed ID: 15721407
[TBL] [Abstract][Full Text] [Related]
4. Current treatment options for endometrial cancer.
Santin AD; Bellone S; O'Brien TJ; Pecorelli S; Cannon MJ; Roman JJ
Expert Rev Anticancer Ther; 2004 Aug; 4(4):679-89. PubMed ID: 15270671
[TBL] [Abstract][Full Text] [Related]
5. Postoperative external beam radiation therapy and concurrent cisplatin followed by carboplatin/paclitaxel for stage III (FIGO 2009) endometrial cancer.
Milgrom SA; Kollmeier MA; Abu-Rustum NR; Tew WP; Sonoda Y; Barakat RR; Alektiar KM
Gynecol Oncol; 2013 Sep; 130(3):436-40. PubMed ID: 23800696
[TBL] [Abstract][Full Text] [Related]
6. Paclitaxel/carboplatin versus cyclophosphamide/adriamycin/cisplatin as postoperative adjuvant chemotherapy for advanced endometrial adenocarcinoma.
Hidaka T; Nakamura T; Shima T; Yuki H; Saito S
J Obstet Gynaecol Res; 2006 Jun; 32(3):330-7. PubMed ID: 16764625
[TBL] [Abstract][Full Text] [Related]
7. Randomized phase III trial of pelvic radiotherapy versus cisplatin-based combined chemotherapy in patients with intermediate- and high-risk endometrial cancer: a Japanese Gynecologic Oncology Group study.
Susumu N; Sagae S; Udagawa Y; Niwa K; Kuramoto H; Satoh S; Kudo R;
Gynecol Oncol; 2008 Jan; 108(1):226-33. PubMed ID: 17996926
[TBL] [Abstract][Full Text] [Related]
8. Association of number of positive nodes and cervical stroma invasion with outcome of advanced endometrial cancer treated with chemotherapy or whole abdominal irradiation: a Gynecologic Oncology Group study.
Tewari KS; Filiaci VL; Spirtos NM; Mannel RS; Thigpen JT; Cibull ML; Monk BJ; Randall ME
Gynecol Oncol; 2012 Apr; 125(1):87-93. PubMed ID: 22155678
[TBL] [Abstract][Full Text] [Related]
9. Postoperative adjuvant chemotherapy with cisplatin, cyclophosphamide, and anthracycline (doxorubicin, epirubicin, pirarubicin) for endometrial cancer.
Yahata H; Hirakawa T; Fujita T; Ariyoshi K; Sonoda K; Amada S; Kobayashi H; Nakano H
Int J Clin Oncol; 2004 Aug; 9(4):317-21. PubMed ID: 15375709
[TBL] [Abstract][Full Text] [Related]
10. The role of multi-modality adjuvant chemotherapy and radiation in women with advanced stage endometrial cancer.
Alvarez Secord A; Havrilesky LJ; Bae-Jump V; Chin J; Calingaert B; Bland A; Rutledge TL; Berchuck A; Clarke-Pearson DL; Gehrig PA
Gynecol Oncol; 2007 Nov; 107(2):285-91. PubMed ID: 17688923
[TBL] [Abstract][Full Text] [Related]
11. Preliminary analysis of RTOG 9708: Adjuvant postoperative radiotherapy combined with cisplatin/paclitaxel chemotherapy after surgery for patients with high-risk endometrial cancer.
Greven K; Winter K; Underhill K; Fontenesci J; Cooper J; Burke T;
Int J Radiat Oncol Biol Phys; 2004 May; 59(1):168-73. PubMed ID: 15093913
[TBL] [Abstract][Full Text] [Related]
12. [Chemotherapy in metastatic or recurrent endometrial carcinoma].
Deppe G; Baumann P; Munkarah A
Zentralbl Gynakol; 2000; 122(7):355-60. PubMed ID: 10951705
[TBL] [Abstract][Full Text] [Related]
13. Effectiveness of postoperative chemotherapy for para-aortic lymph node metastasis of endometrial cancer.
Takeshima N; Umayahara K; Fujiwara K; Hirai Y; Takizawa K; Hasumi K
Gynecol Oncol; 2006 Aug; 102(2):214-7. PubMed ID: 16457876
[TBL] [Abstract][Full Text] [Related]
14. [Evaluation of a new anti-cancer drug regimen for endometrial cancer].
Fushiki H; Hidaka T; Hori S; Fujimura M; Yamakawa Y; Izumi R
Gan To Kagaku Ryoho; 1998 Jan; 25(1):75-8. PubMed ID: 9464332
[TBL] [Abstract][Full Text] [Related]
15. Adjuvant chemotherapy as treatment of high-risk stage I and II endometrial cancer.
Aoki Y; Watanabe M; Amikura T; Obata H; Sekine M; Yahata T; Fujita K; Tanaka K
Gynecol Oncol; 2004 Aug; 94(2):333-9. PubMed ID: 15297170
[TBL] [Abstract][Full Text] [Related]
16. [A case of histological complete remission by preoperative intraarterial infusion chemotherapy].
Taniguchi Y; Matsuo M; Umeki H; Tada M; Kohyama A; Kuwae C; Kitada H; Ohtsuka H
Gan To Kagaku Ryoho; 1995 Sep; 22(11):1702-5. PubMed ID: 7574797
[TBL] [Abstract][Full Text] [Related]
17. New aspects of adjuvant therapy in endometrial cancer: current standards and future directions.
Sehouli J; Koensgen D; Oskay-Ozcelik G; Mustea A
Crit Rev Oncol Hematol; 2008 Sep; 67(3):204-12. PubMed ID: 18407513
[TBL] [Abstract][Full Text] [Related]
18. The relationship between histology and outcome in advanced and recurrent endometrial cancer patients participating in first-line chemotherapy trials: a Gynecologic Oncology Group study.
McMeekin DS; Filiaci VL; Thigpen JT; Gallion HH; Fleming GF; Rodgers WH;
Gynecol Oncol; 2007 Jul; 106(1):16-22. PubMed ID: 17574073
[TBL] [Abstract][Full Text] [Related]
19. [Adjuvant chemotherapy with cyclophosphamide, adriamycin, and CDDP (CAP) for high risk endometrial cancer after complete surgery].
Tsunoda H; Nishida M; Arisawa Y; Sato T; Oki A; Nishide K; Ichikawa Y; Kubo T
Nihon Sanka Fujinka Gakkai Zasshi; 1996 Jan; 48(1):45-51. PubMed ID: 8576621
[TBL] [Abstract][Full Text] [Related]
20. [Effects of postoperative chemotherapy on the prognosis of patients with high-risk early stage endometrial cancer].
Wen HW; Tian F; Ma L; Liao QP
Zhonghua Fu Chan Ke Za Zhi; 2009 Mar; 44(3):196-9. PubMed ID: 19570445
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]